Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This Riot Platforms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Author: Avi Kapoor | September 24, 2025 02:35pm

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Needham analyst Gerald Pascarelli initiated coverage on The Vita Coco Company, Inc (NASDAQ:COCO) with a Hold rating. Vita Coco shares closed at $41.19 on Tuesday. See how other analysts view this stock.
  • Arete Research initiated coverage on Riot Platforms (NASDAQ:RIOT) with a Buy rating and announced a price target of $26. Riot Platforms shares closed at $41.19 on Tuesday. See how other analysts view this stock.
  • TD Cowen analyst Joseph Thome initiated coverage on Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) with a Buy rating and announced a price target of $95. Mirum Pharmaceuticals shares closed at $73.62 on Tuesday. See how other analysts view this stock.
  • Oppenheimer analyst Timothy Horan initiated coverage on Kyivstar Group Ltd. (NASDAQ:KYIV) with an Outperform rating and announced a price target of $20. Kyivstar Group shares closed at $11.78 on Tuesday. See how other analysts view this stock.
  • Wedbush analyst Martin Fan initiated coverage on Sana Biotechnology, Inc. (NASDAQ:SANA) with an Outperform rating and announced a price target of $5. Sana Biotechnology shares closed at $3.26 on Tuesday. See how other analysts view this stock.

Considering buying RIOT stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: COCO KYIV MIRM RIOT SANA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist